Coccidioidomycosis Market Information Related To Pipeline Products, News and Deals is Available In The Report
About Coccidioidomycosis Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis - Pipeline Review, H1 2018, provides an overview of the Coccidioidomycosis (Infectious Disease) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581030
Coccidioidomycosis, also called Valley fever, is an infection caused by the fungus Coccidioides. Symptoms include fever, cough, chest pain, chills, headache, fatigue and joint aches. Risk factors include weakened immune system, age, pregnancy, race and environmental exposure. Treatment includes antifungal medications.
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Coccidioidomycosis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Coccidioidomycosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Request for TOC @ https://www.marketresearchreports.biz/reports/1581030/coccidioidomycosis-pipeline-review-h1-2018-market-research-reports/toc
The Coccidioidomycosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Coccidioidomycosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 1, 1 and 3 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Coccidioidomycosis (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Coccidioidomycosis (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Coccidioidomycosis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Coccidioidomycosis (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Coccidioidomycosis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Coccidioidomycosis (Infectious Disease)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Coccidioidomycosis (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Coccidioidomycosis (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
View Report @ https://www.marketresearchreports.biz/reports/1581030/coccidioidomycosis-pipeline-review-h1-2018-market-research-reports
Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Coccidioidomycosis - Overview
Coccidioidomycosis - Therapeutics Development
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Coccidioidomycosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Coccidioidomycosis - Companies Involved in Therapeutics Development
Amplyx Pharmaceuticals Inc
Valley Fever Solutions Inc
Viamet Pharmaceuticals Inc
Coccidioidomycosis - Drug Profiles
Amphotericin B sodium - Drug Profile
Mechanism Of Action
APX-001 - Drug Profile
Mechanism Of Action
coccidioidomycosis vaccine - Drug Profile
Mechanism Of Action
nikkomycin Z - Drug Profile
Mechanism Of Action
VT-1161 - Drug Profile
Mechanism Of Action
VT-1598 - Drug Profile
Mechanism Of Action
Coccidioidomycosis - Dormant Projects
Coccidioidomycosis - Product Development Milestones
Featured News & Press Releases
Jul 13, 2017: FDA Grants Fast Track Designation to VT-1598 for Treatment of Valley Fever
May 17, 2017: Viamet To Present Data on VT-1598 at The American Society for Microbiology's ASM Microbe 2017 Conference
Nov 16, 2016: FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Multiple Invasive Fungal and Mold Infections
Sep 15, 2016: FDA Grants QIDP Designation to VT-1598 for Treatment of Valley Fever
Jun 14, 2016: Amplyx Pharmaceuticals Announces Qualified Infectious Disease Product Designation for APX001 in Three Life-threatening Fungal Infections
May 25, 2016: Viamet Receives Orphan Drug Designation from the FDA for VT-1598 for the Treatment of Coccidioidomycosis
May 20, 2015: Viamet Announces NIH Grant for Compounds Directed at Valley Fever
Expert Panel Validation
Buy Now @ https://www.researchmoz.com/checkout?rep_id=1581030&licType=S
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coccidioidomycosis Market Information Related To Pipeline Products, News and Deals is Available In The Report here
News-ID: 955807 • Views: 235
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is
More Releases for Coccidioidomycosis
Coccidioidomycosis Drug Market Trends 2022 | Segmentation, Outlook, Industry Rep …
The global coccidioidomycosis drug market is expected to grow at a significant CAGR during the forecast period (2022-2028). The fungal infection causes coccidioidomycosis, popularly known as valley fever. The fungus that causes coccidioidomycosis is called coccidioides, and it lives in soil in Mexico, the southern US, Central America, and South America. Valley fever is spread by inhaling fungus spores that are present in the air. Valley fever is characterized by
Coccidioidomycosis Drug Market 2021 Applications, Business Strategies, Opportuni …
The report titled “Global Coccidioidomycosis Drug MARKET “is one of the most comprehensive and important additions to market research studies. It offers detailed research and analysis of key aspects of the Coccidioidomycosis Drug market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Coccidioidomycosis Drug market. Market Participants can use the analysis on
Global Coccidioidomycosis Drug Market 2020 Amplyx Pharmaceuticals Inc, Valley Fe …
The report "Global Coccidioidomycosis Drug Market" evaluates the present and future market opportunities of Coccidioidomycosis Drug business. The analysis study sheds lightweight on a number of the main drivers and restraints factors influencing the expansion of the Coccidioidomycosis Drug market. The market is separate on the idea of product sort, Coccidioidomycosis Drug makers, application, and countries. practicableness of investment study, Coccidioidomycosis Drug market standing from 2015 to 2020, Coccidioidomycosis Drug
Global Coccidioidomycosis Market Research Report 2019 | Global Key Player -Amply …
This research study added to the broad database of Market Research Hub (MRH) focusing on the Coccidioidomycosis - Pipeline Review, H1 2019 delivers an in-depth outlook to present information about executive summary and key performance indicators. Furthermore, readers can gather knowledge about the economic status, demographics and competitive landscape which is prevailing in the concerned industry during the review period, 2019. Overall, the purpose of this assessment is to present
Coccidioidomycosis Drug Market Outlook To 2023 – Amplyx Pharmaceuticals Inc, V …
Nov 2018, New York USA (News)- Coccidioidomycosis, commonly known as cocci, Valley fever, as well as California fever, desert rheumatism, and San Joaquin Valley fever, is a mammalian fungal disease caused by Coccidioides immitis or Coccidioides posadasii. Coccidioidomycosis is endemic in certain parts of Arizona, California, Nevada, New Mexico, Texas, Utah, and northern Mexico. C. immitis is a dimorphic saprophytic fungus that grows as a mycelium in the soil and produces
Coccidioidomycosis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Coccidioidomycosis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis - Pipeline Review, H2 2017, provides an overview of the Coccidioidomycosis (Infectious Disease) pipeline landscape. Coccidioidomycosis, also called Valley fever, is an infection caused by the fungus Coccidioides. Symptoms include fever, cough, chest pain, chills, headache,